Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF
$2.34
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 110.92M | 96.09M | 250.40M | -44.97M | 85.13M |
| Total Depreciation and Amortization | -59.58M | 58.98M | -- | 116.06M | -62.92M |
| Total Amortization of Deferred Charges | -7.21M | 7.13M | -- | 14.09M | -4.35M |
| Total Other Non-Cash Items | -765.37M | 817.96M | -786.20M | 640.72M | -581.31M |
| Change in Net Operating Assets | 920.36M | -911.00M | -- | -142.90M | 743.01M |
| Cash from Operations | 199.12M | 69.16M | -535.81M | 583.00M | 179.55M |
| Capital Expenditure | -57.57M | -37.44M | -31.14M | -43.95M | -34.55M |
| Sale of Property, Plant, and Equipment | 74.60K | 790.40K | 20.50K | 180.20K | 43.00K |
| Cash Acquisitions | -316.10K | 312.90K | -- | 0.00 | 0.00 |
| Divestitures | 136.60K | -135.20K | -- | -- | -- |
| Other Investing Activities | 239.54M | -514.51M | -70.43M | -195.91M | -10.91M |
| Cash from Investing | 181.86M | -550.98M | -101.55M | -239.68M | -45.42M |
| Total Debt Issued | 1.54B | 3.89B | 4.31B | 1.45B | 1.44B |
| Total Debt Repaid | -2.33B | -2.52B | -3.13B | -2.46B | -963.99M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -118.86M | -90.70M | -11.55M | -106.92M | -45.99M |
| Other Financing Activities | 736.44M | 182.67M | -64.08M | 188.86M | -153.69M |
| Cash from Financing | -127.41M | 123.43M | 141.03M | -221.53M | -1.09M |
| Foreign Exchange rate Adjustments | -196.10K | -118.70K | 870.00K | 295.50K | 101.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 253.37M | -358.50M | -495.46M | 122.09M | 133.15M |